Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2008, Genosco is a clinical-stage biotechnology company pursuing the discovery and development of novel small-molecule drugs to treat patients with unmet medical needs. We utilize a highly targeted approach with expertise in selective kinase inhibitors. Currently, we have discovered several master scaffolds selectively inhibiting protein kinases which are enzymes that transfer phosphate groups to proteins and are ke...
Founded in 2008, Genosco is a clinical-stage biotechnology company pursuing the discovery and development of novel small-molecule drugs to treat patients with unmet medical needs. We utilize a highly targeted approach with expertise in selective kinase inhibitors. Currently, we have discovered several master scaffolds selectively inhibiting protein kinases which are enzymes that transfer phosphate groups to proteins and are key players in virtually all signal pathways.

List your booth number for exhibitions, ask us